Lux Capital is a venture capital firm that invests in early-stage science and technology companies. The firm was founded in 2000 by Peter Hebert, Joshua Kushner, and Robert Kraft, and has since made investments in over 100 companies.
Lux Capital invests in companies across a wide range of industries, including healthcare, biotechnology, artificial intelligence, robotics, and clean energy. In recent years, the firm has been active in investing in companies working on developing new treatments for cancer, improving the accuracy of medical diagnosis, and developing new clean energy technologies.
The firm has helped to finance some of the most innovative and disruptive companies in the world, including plant-based meat company Impossible Foods, gene editing company CRISPR Therapeutics, and autonomous driving company Aurora Innovation. Lux Capital is committed to helping the most promising companies in the world change the way we live and work.
Lux Capital is a venture capital firm that invests in game-changing technologies. The company was founded in 2000 by Peter Hebert, a former software engineer, and Simon Healy, a former investment banker.
Lux Capital has invested in a number of companies that are making waves in the technology industry, including Oculus Rift, the virtual reality headset maker that was acquired by Facebook for $2 billion.
Other notable investments include AppNexus, the online advertising platform, and Planet Labs, the satellite imaging company.
Lux Capital is headquartered in New York City.
Lux Capital has a team of experienced investors and entrepreneurs who are passionate about backing bold ideas. The firm has a long history of success in backing companies that are pushing the envelope and changing the world.
One of the most recent companies to receive backing from Lux Capital is Cloud9, a cloud computing startup that is shaking up the industry. Cloud9 is revolutionizing the way businesses use and store data, and the company has already seen tremendous success.
The team at Lux Capital is excited to continue backing bold ideas like Cloud9 that have the potential to change the world.
The firm has a long track record of successful investments in many different industries, including healthcare, energy, and consumer technology. This is a testament to the firm's ability to identify and invest in companies with strong potential.
One of the firm's most notable recent investments is in healthcare technology company Crescendo Bioscience. Crescendo Bioscience is a leading provider of molecular diagnostics for autoimmune diseases. The firm's investment in Crescendo Bioscience has been very successful, and the company is now one of the leading providers of molecular diagnostics in the healthcare industry.
The firm's investment in Crescendo Bioscience is just one example of the firm's successful investments in healthcare. The firm has also made successful investments in other healthcare companies, including an investment in Health Catalyst, a leading provider of data and analytics tools for healthcare.
The firm's investment in Crescendo Bioscience is just one example of the firm's successful investments in different industries. The firm has a long track record of successful investments in many different industries, including healthcare, energy, and consumer technology. This is a testament to the firm's ability to identify and invest in companies with strong potential.
At Lux Capital, we believe that companies can be a force for good in the world. We are committed to investing in and supporting companies that are making a positive impact on the world.
Lux Capital has a long history of supporting companies that are making a difference. We were an early investor in Athenahealth, a company that is transforming healthcare. We also backed companies like Cambrian Genomics, which is making DNA sequencing more accessible and affordable, and Helion Energy, which is developing cleaner and more efficient energy solutions.
We are proud to be a part of the positive change that these companies are bringing to the world. We will continue to invest in companies that are making a positive impact on the world, and we look forward to helping them grow and scale.